SoftVue, the whole breast ultrasound imaging device created by two scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, is currently undergoing review by the U.S. Food and Drug Administration (FDA) for market clearance. It's anticipated that this first application clearance could come this spring, with several other FDA submissions to follow over the next couple of years. This promising imaging tool has the potential to aid in detecting breast cancer earlier, especially in women with dense breasts. Peter Littrup , M.D., and Neb Duric, Ph.D., of the Karmanos Cancer Institute and Wayne State University School of Medicine, and their team have been working to perfect the SoftVue technology for more than a decade.

http://www.news-medical.net/news/20130129/Karmanos-Cancer-Institutee28099s-SoftVue-system-under-FDA-review-for-market-clearance.aspx
http://mms.tveyes.com/Transcript.asp?StationID=2785&DateTime=1%2F29%2F2013+5%3A14%3A29+AM&LineNumber=&MediaStationID=2785&playclip=True&RefPage=
http://detroit.cbslocal.com/2013/01/28/ultrasound-breast-cancer-imaging-invented-at-karmanos-closer-to-fda-approval/